跳至主要内容
临床试验/CTRI/2026/01/100711
CTRI/2026/01/100711尚未招募不适用

A Single Arm Clinical Trial to Study the Effect of Shatapushpa Churna in Improving the Attention Span in Children of 6 to 13 Years of Age.

Dr Gautami Kashinath Nimase1 个研究点 分布在 1 个国家目标入组 66 人开始时间: 2026年1月20日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
66
试验地点
1

研究概览

简要总结

TITLE: A Single Arm Clinical Trial to Study the Effect of Shatapushpa Churna in Improving the Attention Span in Children of 6 to 13 Years of Age.

INTRODUCTION: Attention span is a key part of a child’s mental  and cognitive development. In the present day academic environment, even healthy school-going children often struggle to concentrate for long periods. This affects their ability to learn, perform well in class, and manage their emotions effectively.

In the past few years, many scientific theories have tried to explain how attention works, but there is no clear, universally accepted way to improve attention in normal children. Most available treatments are designed for children with conditions like ADHD and may not be suitable for healthy children.

In Kashyapa Samhita, Shatapushpa (Anethum Sowa), has been mentioned for its role in enhancing Medha and Smriti. Shatapushpa (Anethum sowa) is a traditional Ayurvedic herb known for enhancing intellect (Medhya) and improving digestion (Agnideepana). A few studies say that it helps to improve IQ in children. Still, there is a lack of research on its specific effect on attention span in normal, healthy school children.

To fill this gap, the current research has been planned to find out the effect of Shatapushpa Churna can improve attention span in children using standard psychological tests (PGI-Children memory scale and Visual Cancellation Task). This will help to confirm its use in improving attention span.

Shatapushpa Beeja (Anethum Sowa) will be purchased from GMC certified pharmacy. Drug will be administered in Churna form for 30 days. All SOP of Churna Vidhi will be strictly followed during and after treatment. Assessment will be done on Day 0 and Day 30. Interim follow up at Day 15.

SAMPLE SIZE: The sample size for the study will be 60 participants. Considering a 10% dropout rate, the total sample size will be 66 participants.

NULL HYPOTHESIS: (HO) Shatapushpa (Anethum Sowa) Churna does not improve the Attention Span in children of 6 to 13 years of age.

ALTERNATE HYPOTHESIS: (H1) Shatapushpa (Anethum Sowa) Churna improves the Attention Span in children of 6 to 13 years of age.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
6.00 Year(s) 至 13.00 Year(s)(—)
性别
All

入选标准

  • 1.Children of age group 6 to 13 years.
  • 2.Selection of Children is irrespective of their gender religion and socioeconomic status.
  • 3.Parents who will give written consent for treatment.

排除标准

  • 1.Mental retardation 2.Learning disability 3.Attention deficit hyperactivity disorder 4.Autism spectrum disorder 5.Gross developmental delay 6.Visual and auditory impairment 7.Chronic illness which hampers cognition in children 8.Severely malnourished children.

研究者

发起方
Dr Gautami Kashinath Nimase
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Gautami Kashinath Nimase

SMBT Ayurved College and Hospital

研究点 (1)

Loading locations...

相似试验